naloxone hydrochloride dihydrate

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 51481-60-8

Where It Comes From

26 FDA-registered drug labelers
Accord Healthcare, Inc
Actavis Pharma, Inc.
Alvogen Inc.
American Health Packaging
Amneal Pharmaceuticals LLC
Asclemed USA, Inc.
AvPAK
Bryant Ranch Prepack
Camber Pharmaceuticals, Inc.
Clinical Solutions Wholesale, LLC
Hikma Pharmaceuticals USA Inc.
Macfarlan Smith Limited
Major Pharmaceuticals
Medisca Inc.
Mylan Pharmaceuticals Inc.
Noramco, LLC
Pharmaron Manufacturing Services (UK) Ltd
Professional Compounding Centers of America
Redpharm Drug
REMEDYREPACK INC.
Rhodes Pharmaceuticals L.P.
Siegfried PharmaChemikalien Minden Gmbh
SpecGx LLC
Spectrum Laboratory Products, Inc.
SUN PHARMACEUTICAL INDUSTRIES, INC.
Unit Dose Solutions, Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 4 drug and cosmetic product listings (FDA).

  • Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate
  • Buprenorphine and Naloxone
  • Buprenorphine and Naloxone Sublingual Film
  • Buprenorphine HCl and Naloxone HCl
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS51481-60-8
PubChem CID20112022
DTXSIDDTXSID90199452
FormulaC19H26ClNO6
Mol. Weight399.9 g/mol
SMILESC=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.O.O.Cl

Data Sources

201120222026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/naloxone hydrochloride dihydrate/cids/JSON

Archive: data/sources/pubchem_name/naloxone hydrochloride dihydrate.json

CAS 51481-60-82026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

bulk match2026-04-07

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json